Australia Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2026

February 2023 | 48 pages | ID: A3865437A9BAEN
MarketLine

Abstracts

Australia Pharmaceuticals Market @Summary, Competitive Analysis and Forecast to 2026

SUMMARY

Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY HIGHLIGHTS

• The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
• The Australian pharmaceuticals market had total revenues of $10.6 billion in 2021, representing a compound annual growth rate (CAGR) of -1.4% between 2016 and 2021.
• Australia’s population is aging, with 21–23% of the population estimated to be aged 65 and over by 2066. Chronic diseases are also becoming increasingly common, and overall, this will continue to drive demand for pharmaceuticals.
• Australia’s domestic pharmaceutical manufacturing capacity is likely to be boosted by the introduction of the Modern Manufacturing Initiative in 2021, which will contribute to market growth going forwards.

SCOPE

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Australia
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Australia
• Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the Australia pharmaceuticals market with five year forecasts by both value and volume

REASONS TO BUY

• What was the size of the Australia pharmaceuticals market by value in 2021?
• What will be the size of the Australia pharmaceuticals market in 2026?
• What factors are affecting the strength of competition in the Australia pharmaceuticals market?
• How has the market performed over the last five years?
• Who are the top competitors in Australia's pharmaceuticals market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths and weaknesses of leading players?
7.4. What strategies do leading players follow?

8 COMPANY PROFILES

8.1. Pfizer Inc.
8.2. Aspen Pharmacare Holdings Ltd
8.3. AstraZeneca PLC
8.4. GSK plc.

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Australia pharmaceuticals market value: $ billion, 2016–21
Table 2: Australia pharmaceuticals market geography segmentation: $ billion, 2021
Table 3: Australia pharmaceuticals market value forecast: $ billion, 2021–26
Table 4: Australia pharmaceuticals market share: % share, by value, 2021
Table 5: Pfizer Inc.: key facts
Table 6: Pfizer Inc.: Annual Financial Ratios
Table 7: Pfizer Inc.: Key Employees
Table 8: Pfizer Inc.: Key Employees Continued
Table 9: Aspen Pharmacare Holdings Ltd: key facts
Table 10: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 11: Aspen Pharmacare Holdings Ltd: Key Employees
Table 12: AstraZeneca PLC: key facts
Table 13: AstraZeneca PLC: Annual Financial Ratios
Table 14: AstraZeneca PLC: Key Employees
Table 15: AstraZeneca PLC: Key Employees Continued
Table 16: GSK plc.: key facts
Table 17: GSK plc.: Annual Financial Ratios
Table 18: GSK plc.: Key Employees
Table 19: GSK plc.: Key Employees Continued
Table 20: Australia size of population (million), 2017–21
Table 21: Australia gdp (constant 2005 prices, $ billion), 2017–21
Table 22: Australia gdp (current prices, $ billion), 2017–21
Table 23: Australia inflation, 2017–21
Table 24: Australia consumer price index (absolute), 2017–21
Table 25: Australia exchange rate, 2017–21

List Of Figures

LIST OF FIGURES

Figure 1: Australia pharmaceuticals market value: $ billion, 2016–21
Figure 2: Australia pharmaceuticals market geography segmentation: % share, by value, 2021
Figure 3: Australia pharmaceuticals market value forecast: $ billion, 2021–26
Figure 4: Forces driving competition in the pharmaceuticals market in Australia, 2021
Figure 5: Drivers of buyer power in the pharmaceuticals market in Australia, 2021
Figure 6: Drivers of supplier power in the pharmaceuticals market in Australia, 2021
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2021
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2021
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2021
Figure 10: Australia pharmaceuticals market share: % share, by value, 2021